Balyasny Asset Management »

Elicio Therapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Elicio Therapeutics (ELTX) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Elicio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Elicio Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Elicio Therapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.6M 245k 10.69
2025-12-31 $1.1M 139k 7.96
2025-09-30 $1.6M 148k 10.94

More positions owned by Balyasny Asset Management

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Warner Bros Discovery Com Ser A Put Option (WBD)
Raytheon Technologies Corp Call Option (RTX)
Select Sector Spdr Tr State Street Fin Call Option (XLFI)
Select Sector Spdr Tr State Street Ene Call Option (XLE)
Lumentum Hldgs Note 0.500% 6/1 (Principal)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Balyasny Asset Management

Top funds holding Elicio Therapeutics

Knoll Capital Management
Vanguard Capital Management
Vanguard Group
Sio Capital Management
Balyasny Asset Management
Geode Capital Management
Marshall Wace
Jane Street
Millennium Management
Citadel Advisors
Vanguard Fiduciary Trust
Susquehanna International
Goldman Sachs Group
683 Capital Management
Northern Trust

View all funds holding Elicio Therapeutics